Rockbridge Investment Management, Lcc Organon & Co. Transaction History

Rockbridge Investment Management, Lcc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $3,274 - $5,178	-299 Reduced 92.86%	23 $336,000
Q3 2022 May 28, 2024	SELL	$23.4 - $34.25 $2,714 - $3,973	-116 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$31.66 - $38.9 $5,445 - $6,690	-172 Reduced 59.72%	116 $3,000
Q1 2022 May 28, 2024	BUY	$30.45 - $39.36 $8,769 - $11,335	288 New	288 $10,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $429 - $534	-15 Reduced 4.45%	322 $10,000
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $9,587 - $12,806	337 New	337 $10,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.